Skip to content

JBIO JBIO FX Effect on Cash

FX Effect on Cash at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$40.3M-232%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$60K-111%
Annexon logo
AnnexonANNX
$1K
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$0+100%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$25M-136%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$72K-116%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's FX effect on cash?
JBIO (JBIO) reported FX effect on cash of -$7K in Q1 2026.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.